Serveur d'exploration sur Heinrich Schütz

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The Impact of Mammalian Gene Regulation Concepts on Functional Genomic Research, Metabolic Engineering, and Advanced Gene Therapies

Identifieur interne : 000989 ( Main/Exploration ); précédent : 000988; suivant : 000990

The Impact of Mammalian Gene Regulation Concepts on Functional Genomic Research, Metabolic Engineering, and Advanced Gene Therapies

Auteurs : Martin Fussenegger [Suisse]

Source :

RBID : ISTEX:D8D5C799D1F03CBDC4A78F9436D06466D370E515

Abstract

Regulation of heterologous gene expression is of prime importance for a wide variety of basic and applied biological research areas including functional genomics, tissue engineering, gene therapy, and biopharmaceutical manufacturing. Initial gene regulation strategies employed endogenous responsive elements, which resulted in pleiotropic interference of transgene expression with host regulatory networks. Current regulation systems are binary and consist of chimeric transactivators and responsive target promoters of heterologous bacterial or insect origin, or they contain artificially designed components. Regulation of generic systems is based on binding of a transactivator to its cognate promoter, which is modulated by specific molecules such as antibiotics or hormones and brings the transactivation domain into contact with a minimal promoter, thereby inducing target gene expression. Binary gene regulation concepts have been significantly refined in recent years with a focus to improve their regulation performance and their compatibility with human‐therapeutic use. In this review we present a detailed analysis of currently available mammalian gene regulation systems and document progress that has pioneered the use of such systems in various aspects of human therapy.

Url:
DOI: 10.1021/bp000129c


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The Impact of Mammalian Gene Regulation Concepts on Functional Genomic Research, Metabolic Engineering, and Advanced Gene Therapies</title>
<author>
<name sortKey="Fussenegger, Martin" sort="Fussenegger, Martin" uniqKey="Fussenegger M" first="Martin" last="Fussenegger">Martin Fussenegger</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D8D5C799D1F03CBDC4A78F9436D06466D370E515</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1021/bp000129c</idno>
<idno type="url">https://api.istex.fr/document/D8D5C799D1F03CBDC4A78F9436D06466D370E515/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001678</idno>
<idno type="wicri:Area/Main/Curation">001583</idno>
<idno type="wicri:Area/Main/Exploration">000989</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Exploration">000989</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">The Impact of Mammalian Gene Regulation Concepts on Functional Genomic Research, Metabolic Engineering, and Advanced Gene Therapies</title>
<author>
<name sortKey="Fussenegger, Martin" sort="Fussenegger, Martin" uniqKey="Fussenegger M" first="Martin" last="Fussenegger">Martin Fussenegger</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Institute of Biotechnology, Swiss Federal Institute of Technology, ETH Zurich, CH‐8093 Zurich</wicri:regionArea>
<wicri:noRegion>CH‐8093 Zurich</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Biotechnology Progress</title>
<title level="j" type="abbrev">Biotechnol Progress</title>
<idno type="ISSN">8756-7938</idno>
<idno type="eISSN">1520-6033</idno>
<imprint>
<publisher>American Chemical Society</publisher>
<pubPlace>USA</pubPlace>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">17</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="1">1</biblScope>
<biblScope unit="page" to="51">51</biblScope>
</imprint>
<idno type="ISSN">8756-7938</idno>
</series>
<idno type="istex">D8D5C799D1F03CBDC4A78F9436D06466D370E515</idno>
<idno type="DOI">10.1021/bp000129c</idno>
<idno type="ArticleID">BTPR129</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">8756-7938</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Regulation of heterologous gene expression is of prime importance for a wide variety of basic and applied biological research areas including functional genomics, tissue engineering, gene therapy, and biopharmaceutical manufacturing. Initial gene regulation strategies employed endogenous responsive elements, which resulted in pleiotropic interference of transgene expression with host regulatory networks. Current regulation systems are binary and consist of chimeric transactivators and responsive target promoters of heterologous bacterial or insect origin, or they contain artificially designed components. Regulation of generic systems is based on binding of a transactivator to its cognate promoter, which is modulated by specific molecules such as antibiotics or hormones and brings the transactivation domain into contact with a minimal promoter, thereby inducing target gene expression. Binary gene regulation concepts have been significantly refined in recent years with a focus to improve their regulation performance and their compatibility with human‐therapeutic use. In this review we present a detailed analysis of currently available mammalian gene regulation systems and document progress that has pioneered the use of such systems in various aspects of human therapy.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Suisse</li>
</country>
</list>
<tree>
<country name="Suisse">
<noRegion>
<name sortKey="Fussenegger, Martin" sort="Fussenegger, Martin" uniqKey="Fussenegger M" first="Martin" last="Fussenegger">Martin Fussenegger</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/SchutzV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000989 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000989 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Musique
   |area=    SchutzV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:D8D5C799D1F03CBDC4A78F9436D06466D370E515
   |texte=   The Impact of Mammalian Gene Regulation Concepts on Functional Genomic Research, Metabolic Engineering, and Advanced Gene Therapies
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Mon Feb 8 17:34:10 2021. Site generation: Mon Feb 8 17:41:23 2021